登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688528 证券简称：秦川物联 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 (二) 非经常性损益项目和金额 √适用 □不适用 单位:元 币种:人民币 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人邵泽华、主管会计工作负责人李婷及会计机构负责人（会计主管人员）罗媛保证季度报告中 财务信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一) 主要会计数据和财务指标 单位：元 币种：人民币 对公司将《公开发行证券的公司信息披露解释性公告第1号——非经常性损益》未列举的项目认定为非 经常性损益项目且金额重大的，以及将《公开发行证券的公司信息披露解释性公告第1号——非经常性 损益》中列举的非经常性损益项目界定为经常性损益的项目，应说明原因。 √适用 □不适用 单位：元 币种：人民币 (三) 主要会计数据、财 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603815 证券简称：交建股份 公告编号：2025-022 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上海证券交易所上市公司自律监管指引第1号——规范运作》和《上海证券交易 所上市公司自律监管指南第1号——公告格式》的规定，将安徽省交通建设股份有限公司（以下简称本 公司或公司）2024年度募集资金存放与使用情况报告如下： 一、 募集资金基本情况 经中国证券监督管理委员会证监许可[2021]18号文核准，公司于2021年6月向社会非公开发行人民币普 通股（A股）119,924,235股，每股发行价为7.26元，募集资金总额为人民币87,064.99万元，根据有关规 定扣除发行费用1,143.70万元后，实际募集资金金额为85,921.30万元。该募集资金已于2021年6月到账。 上述资金到账情况业经容诚会计师事务所（特殊普通合伙）容诚验字[2021]230Z0133号《验资报告》验 证。公司对募集资金采取了专户存储管理。 2024年度，本公司 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002537 证券简称：海联金汇 公告编号：2025-035 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经审计 □是 R否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是R 否 （二） 非经常性损益项目和金额 R适用 □不适用 □适用 R不适用 公司不存在将《公开发行证券的公司信息披露解释性公告第1号——非经常性损益》中列举的非经常性 损益项目界定为经常性损益的项目的情形。 （三） 主要会计数据和财务指标发生变动的情况及原因 R适用 □不适用 二、股东信息 （一） 普通股股东总数和表决权恢复的优先股股东数量及前十名股东持股情况表 单位：元 其他符合非经 ...

Fundraising Overview - The company raised a total of RMB 754.56 million through the issuance of 32 million shares at a price of RMB 23.58 per share, with a net amount of RMB 685.86 million after deducting underwriting fees [1] - As of December 31, 2023, the cumulative amount directly invested in fundraising projects was RMB 285.64 million, with an unutilized amount of RMB 438.47 million [2] Fund Utilization in 2024 - In 2024, the company utilized RMB 284.99 million of the raised funds, including expenditures for various projects such as RMB 0.79 million for the automated production base and RMB 18.01 million for acquiring equity in Hongtong Technology [3] - By December 31, 2024, the total amount directly invested in fundraising projects reached RMB 570.63 million, with an unutilized balance of RMB 158.55 million [3][4] Fund Management and Storage - The company established a dedicated account for the management and storage of raised funds, ensuring compliance with relevant regulations and protecting investor interests [4][5] - As of December 31, 2024, the total balance in the fundraising special account was RMB 77.15 million, which included cash management products [6] Changes in Fund Usage - The company approved changes in the use of funds, reallocating RMB 18.01 million from the automated production base project to acquire a 60% stake in Hongtong Technology [8][19] - Additionally, RMB 15.49 million was reallocated to increase capital for Hongtong Technology's factory capacity enhancement in Thailand [19] Idle Fund Management - The company decided to use up to RMB 300 million of idle funds for cash management, investing in low-risk, liquid financial products [6][14] - As of December 31, 2024, the cash management products balance was RMB 81.40 million, which included RMB 34.40 million in seven-day notice deposits and RMB 47 million in large time deposits [6][14] Fund Usage Reporting - The company confirmed that all disclosed information regarding the use of raised funds is timely, accurate, and complete, complying with relevant laws and regulations [24] - The special report on fundraising was approved by the board on April 28, 2025 [25]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002099 证券简称：海翔药业 公告编号：2025-012 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 根据中国证券监督管理委员会《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求 （2022年修订）》（证监会公告〔2022〕15号）和深圳证券交易所印发的《深圳证券交易所上市公司自 律监管指引第1号——主板上市公司规范运作（2023年12月修订）》（深证上〔2023〕1145号）的规 定，将本公司募集资金2024年度存放与使用情况专项说明如下。 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 经中国证券监督管理委员会证监许可〔2016〕765号文核准，并经深圳证券交易所同意，本公司由主承 销商国泰君安证券股份有限公司采用非公开发行方式，向特定对象非公开发行人民币普通股（A股）股 票9,989.0023万股，发行价为每股人民币10.28元，共计募集资金102,686.94万元，坐扣承销和保荐费用 1,000万元后的募集资金为101,686.94万元，已由主承销商国泰君安证 ...

Core Viewpoint - Zhejiang Zhengte Co., Ltd. reported a net profit of -13,981,036.69 yuan for the year 2024, leading to a proposal not to distribute profits for that year [8][9]. Financial Data - The company confirmed that it does not need to restate previous accounting data [3]. - The total undistributed profits as of December 31, 2024, amounted to 363,294,206.32 yuan, while the parent company reported a net profit of 108,725,995.47 yuan [8][9]. - The company plans to carry forward the accumulated undistributed profits to meet operational needs [9]. Asset Impairment - For the year 2024, the company recognized an asset impairment loss of 3,135,700 yuan, which includes credit impairment losses of 2,682,600 yuan and asset impairment losses of 581,800 yuan [16]. - In the first quarter of 2025, the company recorded an asset impairment loss of 11,751,600 yuan, with credit impairment losses of 9,008,100 yuan and asset impairment losses of 2,743,500 yuan [41]. Daily Related Transactions - The company anticipates daily related transactions with a total amount not exceeding 30 million yuan for 2025, based on the execution of 17,540,500 yuan in actual transactions in 2024 [19][20]. - The company has established relationships with several related parties, including Zhejiang Zhengte Gaoxiu Garden Materials Co., Ltd., which is a joint venture [20][25]. Compensation Plan - The proposed compensation plan for directors, supervisors, and senior management for 2025 includes a pre-tax allowance of 60,000 yuan per year for independent directors, with other directors and senior management receiving salaries based on their positions [31][34]. - The compensation will be linked to the company's long-term development and annual performance [32]. Annual Performance Meeting - The company will hold an annual performance meeting on May 9, 2025, to communicate with investors and address their concerns [47][49]. - Investors can submit questions before the meeting through designated online platforms [48].

Group 1 - The company has announced the remuneration plan for directors, supervisors, and senior management for the year 2025, effective from January 1 to December 31, 2025 [1][5] - Independent directors will receive an annual allowance of RMB 60,000, paid quarterly [1][6] - Non-independent directors will receive remuneration based on their positions and performance evaluations, with no additional director allowance [2][3] Group 2 - The company has proposed to reappoint the accounting firm, Zhihong Certified Public Accountants, for the 2025 annual audit, with the decision pending approval at the 2024 annual shareholders' meeting [9][18] - Zhihong CPA has a workforce of nearly 6,000, including 1,359 registered accountants, and reported a revenue of RMB 2.703 billion in 2023, with RMB 2.205 billion from audit services [9][10] - The audit committee has reviewed and approved the reappointment, citing the firm's professional competence and commitment to independent auditing [16][18] Group 3 - The company has decided to cancel the unvested restricted stock from the 2022 incentive plan due to unmet performance conditions for the third vesting period, which required a 60% growth in net profit from 2021 to 2024 [26][28] - The cancellation of the restricted stock will not materially affect the company's financial status or management stability [27][28] - The decision aligns with the regulations of the stock incentive management measures and does not harm the interests of the company or its shareholders [28][29] Group 4 - The company has approved the provision for asset impairment for the year 2024, amounting to a total of RMB 17.903 million, which includes RMB 4.031 million for credit impairment losses [31][33] - The impairment provision reflects a comprehensive assessment of the company's assets to ensure accurate financial reporting [31][34] - The impairment will impact the consolidated profit before tax by RMB 21.934 million [33] Group 5 - The company has announced a change in accounting policies in accordance with the Ministry of Finance's new interpretations, effective from January 1, 2024, which will not affect previously disclosed financial statements [37][38] - The changes include adjustments related to the classification of current and non-current liabilities and the accounting treatment of certain transactions [38][40] - The company confirms that the changes comply with relevant laws and regulations and will not harm the interests of the company or its shareholders [42] Group 6 - The company has scheduled its 2024 annual shareholders' meeting for May 22, 2025, with both on-site and online voting options available [44][49] - Shareholders must register to attend the meeting, and specific procedures for voting and attendance have been outlined [56][59] - The meeting will address various proposals that have been previously approved by the board and supervisory committee [50][51]

Financial Performance - The company reported a total of 2,505.35 MW in new orders during the reporting period, representing an increase of 461.55% compared to the same period last year [4] - Cumulative orders on hand reached 18,101.65 MW, up 98.79% year-on-year, with 4,494.40 MW of these being awarded but not yet contracted [4] Asset Impairment - The company has decided to recognize an asset impairment provision totaling 12,237.38 million RMB for the first quarter of 2025, which will reduce the operating profit by 7,743.63 million RMB after considering reversals [13] - Specific provisions include 753.57 million RMB for inventory impairment due to a decline in product sales prices and fluctuations in raw material costs [9] - The company plans to add a provision of 292.27 million RMB for contract asset impairment, which will increase operating profit by 1,216.73 million RMB after considering reversals [11] Governance and Insurance - The company is proposing to purchase liability insurance for its directors, supervisors, and senior management for the period from July 1, 2025, to June 30, 2026, with a compensation limit of up to 200 million RMB [17] - The insurance premium is expected to be no more than 900,000 RMB, including VAT [17] Shareholder Meeting - The annual shareholder meeting is scheduled for May 23, 2025, with both on-site and online voting options available [23][24] - The meeting will discuss various matters, including the independent director's annual report [25]

登录新浪财经APP 搜索【信披】查看更多考评等级 1、本次计提减值准备的原因 根据《企业会计准则》和公司财务规章制度的规定，公司于2024年末对应收票据、应收账款、其他应收 款、合同资产、存货、固定资产、无形资产等相关资产进行了减值迹象判断，认为上述资产中的部分资 产存在一定的减值迹象。公司本着谨慎性原则，对可能发生减值损失的相关资产计提信用、资产减值准 备。 2、本次计提减值准备的范围和总金额 公司2024年末有迹象可能发生减值的资产有应收票据、应收账款、其他应收款、合同资产和存货。经减 值测试，本年度应计提信用、资产减值损失共计47,155,270.86元。 减值测试结果汇总如下表： ■ 3、公司对本次计提减值准备的审批程序 本次计提减值准备事项，已经公司第七届董事会第三十四次会议及第七届监事会第九次会议审议通过。 二、本次计提减值准备对公司的影响 本次计提减值准备，将减少公司2024年度归属于母公司所有者净利润39,913,516.53元，相应减少公司归 属于母公司股东的所有者权益。本次计提减值准备已经利安达会计师事务所（特殊普通合伙）审计确 认。 三、本次计提减值准备的确认标准及计提方法 本次计提的信 ...

Core Viewpoint - The company plans to recognize an asset impairment provision totaling 78.06 million yuan for the first quarter of 2025, reflecting a proactive approach to financial management and transparency [7][9]. Financial Data Summary - The financial statements for the first quarter of 2025 are unaudited, and the company has confirmed the accuracy and completeness of the financial information provided [3][6]. - The company reported a total asset impairment provision of 78.06 million yuan, which will reduce the consolidated profit for the first quarter by the same amount [9]. Impairment Provision Details - The breakdown of the impairment provision includes: - 227,300 yuan for notes receivable based on a credit loss rate of 0.5% [7]. - 76.73 million yuan for accounts receivable, categorized into five groups based on credit risk characteristics [7][8]. - 1.08 million yuan for other receivables [8]. - 26,000 yuan for contract assets [8]. - A reversal of 5,200 yuan for inventory write-downs due to improved net realizable value [8]. Impact on Financial Position - The recognition of the impairment provision is expected to provide a more accurate representation of the company's financial status, while the overall financial condition remains stable with sufficient liquidity [9].